“…SCS has been shown to augment CBF and speculated to protect the brain from focal ischemia in a large series of experiments, both on animals and on humans [47,48,49,50,51,52,53], and has been proposed for the treatment of several cerebral low-perfusion syndromes [54,55,56,57,58,59,60,61,62,63,64,65,66,67]. However, there is not yet an ultimate scientific explanation; moreover, a clear understanding of the mechanisms elicited by SCS is still lacking [4,53,68].…”